Product
BAT2306
2 clinical trials
1 indication
Indication
PsoriasisClinical trial
A Multicenter, Randomized, Double-Blind, Parallel-Arm, Phase 3 Study to Compare Efficacy and Safety of BAT2306 With Cosentyx® in Patients With Moderate to Severe Plaque PsoriasisStatus: Active (not recruiting), Estimated PCD: 2024-07-31
Clinical trial
A Randomized, Double-blinded, Single-dose, 3-arms Parallel, Comparative Study to Evaluate the Pharmacokinetics and Safety of BAT2306 Injection vs Secukinumab Injection (Cosentyx®) in Healthy Chinese Male SubjectsStatus: Completed, Estimated PCD: 2023-05-03